Safinamide
| CAS No. | 133865-89-1 | Cat. No. | BCP12082 |
| Name | Safinamide | ||
| Synonyms | EMD 1195686;FCE 26743;EMD-1195686;EMD1195686;FCE-26743; | ||
| Formula | C17H19FN2O2 | M. Wt | 302.34 |
| Description | Safinamide (EMD 1195686; FCE 26743; ) is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, Safinamide (EMD 1195686; FCE 26743; ) is voltage-dependent sodium and calcium channel blocker. Safinamide (EMD 1195686; FCE 26743; ) appears to bind to the batrachotoxin-sensitive site 2 of the voltage-sensitive sodium channels. Safinamide blocks N and L-type calcium channels and inhibits glutamate and aspartate release from synaptic terminals. | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | Monoamine Oxidase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.